- Home
- CRNT vs NYXH Comparison
CRNT vs NYXH Comparison
Compare CRNT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- NYXH
- Stock Information
- Founded
- CRNT 1996
- NYXH 2009
- Country
- CRNT Israel
- NYXH Belgium
- Employees
- CRNT N/A
- NYXH N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- NYXH Medical/Dental Instruments
- Sector
- CRNT Technology
- NYXH Health Care
- Exchange
- CRNT Nasdaq
- NYXH Nasdaq
- Market Cap
- CRNT 218.8M
- NYXH 185.5M
- IPO Year
- CRNT 2000
- NYXH 2021
- Fundamental
- Price
- CRNT $2.42
- NYXH $6.10
- Analyst Decision
- CRNT Strong Buy
- NYXH Strong Buy
- Analyst Count
- CRNT 4
- NYXH 3
- Target Price
- CRNT $5.50
- NYXH $15.00
- AVG Volume (30 Days)
- CRNT 776.5K
- NYXH 83.5K
- Earning Date
- CRNT 11-12-2025
- NYXH 11-05-2025
- Dividend Yield
- CRNT N/A
- NYXH N/A
- EPS Growth
- CRNT 34.68
- NYXH N/A
- EPS
- CRNT 0.15
- NYXH N/A
- Revenue
- CRNT $380,518,000.00
- NYXH $5,793,306.00
- Revenue This Year
- CRNT N/A
- NYXH $85.62
- Revenue Next Year
- CRNT $7.47
- NYXH $320.09
- P/E Ratio
- CRNT $16.20
- NYXH N/A
- Revenue Growth
- CRNT 5.06
- NYXH 2.94
- 52 Week Low
- CRNT $1.82
- NYXH $4.35
- 52 Week High
- CRNT $5.73
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- CRNT 59.11
- NYXH 65.06
- Support Level
- CRNT $2.25
- NYXH $4.36
- Resistance Level
- CRNT $2.49
- NYXH $6.75
- Average True Range (ATR)
- CRNT 0.10
- NYXH 0.30
- MACD
- CRNT 0.00
- NYXH 0.26
- Stochastic Oscillator
- CRNT 54.47
- NYXH 82.01
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.